Alphabet Inc.
Mountain View, CA 4 13Fs · since 2025 Q3
- $99.1B
- 28 Positions
- 2026 Q2
- +2367.2% QoQ
- Top 5 98.5%
Portfolio
top 5 98.5% · top 10 99.5%
- SPCX - Space Exploration 95.0%
- Planet Labs 1.2%
- ASTS - Ast Spacemobile 0.8%
- CME - Cme 0.8%
- ARM - Arm 0.7%
- RVMD - Revolution Medicines 0.5%
- Freshworks 0.2%
- Parabilis Medicines 0.1%
- Tempus Ai 0.1%
- Gitlab 0.1%
- Uipath 0.1%
- Ethos 0.1%
- Other 0.3%
AUM over time
Latest book
| SPCX - Space Exploration | 95.05% | New | $94.2B | 551,189,500 | $170.86 | $94.2B | +551,189,500 | +$94.2B |
| Planet Labs | 1.18% | Hold | $1.2B | 35,248,893 | $33.13 | $1.2B | — | — |
| ASTS - Ast Spacemobile | 0.80% | Hold | $795M | 8,943,486 | $88.86 | $795M | — | — |
| CME - Cme | 0.78% | Hold | $769M | 3,484,020 | $220.83 | $769M | — | — |
| ARM - Arm | 0.70% | Hold | $695M | 1,960,784 | $354.57 | $695M | — | — |
| RVMD - Revolution Medicines | 0.56% | Reduce −10.5% | $552M | 2,946,619 | $187.28 | $552M | −345,906 | +$232M |
| Freshworks | 0.17% | Hold | $164M | 16,206,643 | $10.12 | $164M | — | — |
| Parabilis Medicines | 0.14% | New | $135M | 4,919,498 | $27.37 | $135M | +4,919,498 | +$135M |
| Tempus Ai | 0.09% | Hold | $90M | 1,551,102 | $57.93 | $90M | — | — |
| Gitlab | 0.08% | Hold | $83M | 2,724,712 | $30.53 | $83M | — | — |
| Uipath | 0.08% | Hold | $76M | 7,034,337 | $10.87 | $76M | — | — |
| Ethos | 0.07% | Reduce −3.9% | $66M | 3,622,604 | $18.14 | $66M | −147,552 | +$24M |
| Prime Medicine | 0.06% | Hold | $61M | 16,562,498 | $3.69 | $61M | — | — |
| Fervo Energy | 0.05% | New | $51M | 1,760,732 | $29.23 | $51M | +1,760,732 | +$51M |
| Paypay | 0.05% | Hold | $45M | 3,125,000 | $14.33 | $45M | — | — |
| Maze Therapeutics | 0.04% | Hold | $41M | 1,388,583 | $29.84 | $41M | — | — |
| Relay Therapeutics | 0.03% | Reduce −9.9% | $26M | 1,410,029 | $18.71 | $26M | −154,144 | +$11M |
| BBOT - Bridgebio Oncology | 0.02% | Hold | $22M | 2,823,126 | $7.62 | $22M | — | — |
| Oscar Health | 0.01% | Hold | $14M | 481,988 | $28.52 | $14M | — | — |
| BEAM - Beam Therapeutics | 0.01% | Hold | $11M | 321,604 | $34.32 | $11M | — | — |
| Vera Therapeutics | 0.01% | Hold | $10M | 241,264 | $42.91 | $10M | — | — |
| Sana Biotechnology | 0.01% | Hold | $10M | 2,812,500 | $3.49 | $10M | — | — |
| Monte Rosa | 0.01% | Reduce −45.6% | $9M | 372,474 | $24.20 | $9M | −311,801 | −$2M |
| Lyell Immunopharma | 0.00% | Hold | $4M | 293,256 | $14.05 | $4M | — | — |
| FIG - Figma | 0.00% | Hold | $4M | 215,582 | $18.09 | $4M | — | — |
| Spero Therapeutics | 0.00% | Hold | $2M | 889,979 | $2.21 | $2M | — | — |
| Hyperfine | 0.00% | Hold | $1M | 898,720 | $1.35 | $1M | — | — |
| AUTL - Autolus Therapeutics | 0.00% | Hold | $1M | 698,262 | $1.60 | $1M | — | — |
| Tenaya Therapeutics | 0.02% | Exit | $632K | 0 | $0.6902 | $632K | −915,705 | −$632K |
filings history
4 periods · normalized AUM · click period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 28 | $99.1B | +2367.2% | 13F-HR | 8/7/2026 | 000165204426000073 |
| 2026 Q1 | 26 | $4B | +55.7% | 13F-HR | 5/8/2026 | 000165204426000051 |
| 2025 Q4 | 29 | $2.6B | +7.1% | 13F-HR | 2/13/2026 | 000165204426000023 |
| 2025 Q3 | 37 | $2.4B | — | 13F-HR | 11/7/2025 | 000165204425000096 |
About
Alphabet Inc.
4 processed 13Fs · since 2025 Q3